Home > Browse Research > Life Sciences > Biotechnology > Biomarkers

Biomarkers: market research reports

Biomarkers market research reports and industry analysis

Biomarkers: Applications and Trends 8/3/2010 \| published by: Espicom Healthcare Intelligence ... development, the number of new NCE and biological products reaching the market has not improved. A new way of conducting research has to be found and much hope and investment is being set by Biomarkers. \| read more...	$1,215.00
Advances in Imaging Biomarkers: Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements 7/9/2010 \| published by: Business Insights ... cannot be obtained in other ways including a drug’s pharmacology and side effect profile, interaction of a drug and its target, delivery of a drug to its target, and the drug’s pharmacokinetic profile. In the ... \| read more...	$3,835.00
Mastering Biomarkers: Five Top Diagnostics Companies to Watch 6/28/2010 \| published by: Decision Resources ... embracing strategies that have enabled them to win on all three fronts. These companies are at the core of industry growth because of their unparalleled strategic decision making, product offerings, market and product diversifi cation, ... \| read more...	$4,600.00
Special Report: Acute Lymphocytic Leukemia—Unmet Needs in Adult and Pediatric Populations Drive Recent Market Developments 6/14/2010 \| published by: Decision Resources ... one group of patients will not necessarily work for others. For example, effective pediatric ALL treatments have not yielded the same results in adult ALL patients. This treatment gap is compounded by lack of understanding ... \| read more...	$9,200.00
How to Enhance the Value of Antiviral Therapies Through Biomarkers and Diagnostics 5/24/2010 \| published by: Decision Resources ... screening to identify disease carriers. However, recurring influenza pandemics- particularly the most recent-have generated new interest among governments as well as pharmaceutical and diagnostics companies in tackling infectious diseases globally. The focus of R&D now ... \| read more...	$4,600.00
Driving Drug and Diagnostic R&D: The Undeniable Influence of Biomarkers 5/24/2010 \| published by: Decision Resources ... The pharma industry has typically lacked an aggressive biomarker strategy for their R&D efforts. Biomarkers were considered as an afterthought, pursued when regulatory agencies demanded them. However, with the focus on safety (by regulators and ... \| read more...	$4,600.00
Global Cancer Biomarkers Market (2010 - 2015) 5/1/2010 \| published by: MarketsandMarkets ... estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market. Biomarker are chemical, physical, or biological parameters that can ... \| read more...	$4,650.00
Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies 5/1/2010 \| published by: Arrowhead Publishers ... this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the pharmaceutical/biotechnology and companion diagnostic markets. Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of ... \| read more...	$2,495.00
Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics 3/1/2010 \| published by: BCC Research ... with trends and forecasts for growth through 2014 Offers a focus on particular applications of epigenomics, including research tools, diagnostics, drugs and cloning/tissue engineering Discusses industry structure including, mergers and acquisitions, distribution of products, government ... \| read more...	$5,450.00
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets 3/1/2010 \| published by: BCC Research ... 2009, and forecasts, with compound annual growth rates (CAGRs) through 2014 Break down aptamer therapeutic markets by disease or application, including cardiovascular, cancer, macular degeneration, siRNA delivery, and infectious diseases Focus on the intellectual landscape, ... \| read more...	$5,450.00
Myelodysplastic Syndromes (High-Risk) 3/1/2010 \| published by: Decision Resources ... market potential of a drug fulﬁlling a key unmet need. This information is critical for evaluating the impact of clinical attributes on physician prescribing of emerging agents, whether the emerging drug is your own or ... \| read more...	$9,200.00
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs 2/1/2010 \| published by: GBI Research ... biomarkers in pharmaceutical drug discovery and clinical services. This pharmaceutical and healthcare report suggests investment decisions in biomarker-based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical trends, mergers and ... \| read more...	$3,500.00
Biomarkers, Tests and Trends for Drug R&D 2/1/2010 \| published by: Takeda Pacific ... tools & technologies, products and R&D services. This report provides a detailed outlook of the market for biomarkers and related genomic, proteomic, or other tests used in drug R&D programs. The research report also touches ... \| read more...	$2,195.00
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics 1/15/2010 \| published by: NeuroInsights, LLC ... system disorder including addiction, Alzheimer’s, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson’s disease, sensory disorders, and sleep disorders. Diagnosis of these disorders is rapidly changing as new tools are developed for more objective and personalized ... \| read more...	$2,995.00
Biomarker and Diagnostic Opportunities Associated with Targeted Cancer Therapies 12/21/2009 \| published by: Decision Resources ... and inform drug safety and efficacy, provide information on disease progression, and aid in the diagnosis of a cancer. The critical role of biomarkers in targeted cancer therapies is underscored by oncologists we surveyed for ... \| read more...	$4,600.00
Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine 12/17/2009 \| published by: Datamonitor ... be able to predict response to expensive biologic therapies and match specific treatments to patients based upon biomarker profiles. Scope Classification and overview of biomarkers used in routine clinical practice across five rheumatology indications. Identification ... \| read more...	$3,800.00
Regulatory and Legislative Activities: Shaping Biomarker and Diagnostic Use and Driving Personalized Medicine 11/13/2009 \| published by: Decision Resources ... to the industry by publishing guidance and requesting commentary. Additionally, recent legislation, such as GINA, is giving companies new opportunities to further their efforts in personalized medicine. However, plenty of barriers still exist: some are ... \| read more...	$4,600.00
Biomarker and Diagnostic Opportunities in Clinical Research for Neurological Diseases 10/13/2009 \| published by: Decision Resources ... earlier than before, nearly every neurology trial is relying on biomarkers and/or has an imaging component. Although some biomarkers and imaging tools are better than others, companies in this market that are aiming to unveil ... \| read more...	$4,600.00
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook 10/1/2009 \| published by: Business Insights ... towards meeting the requirements of the clinical and regulatory communities with the first DNA microarray test being approved by the US FDA in 2007. Further development of microarrays heralds the introduction of faster diagnosis times ... \| read more...	$3,835.00
European Biomarker Analysis Market 9/30/2009 \| published by: Frost & Sullivan This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015. \| read more...	$6,500.00
Biomarkers- Advanced Technologies and Global Market (2009-2014) 9/9/2009 \| published by: MarketsandMarkets ... also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions. The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % ... \| read more...	$4,650.00
Uncovering Biomarker and Diagnostic Opportunities in Immune and Inflammatory Diseases 8/21/2009 \| published by: Decision Resources ... associate genes with disease, and develop diagnostics, a healthy commercial market for diagnostic technologies and biomarker-based products in immune and infl ammatory therapeutic areas is still years away. The present opportunity is to identify biomarkers ... \| read more...	$4,600.00
Expanding Applications of Personalized Medicine: Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach 8/1/2009 \| published by: Business Insights ... of nutrition means that better nutritional care of patients is increasingly on the agenda of governments and healthcare professionals alike. Add to that the rise in diseases (often associated with aging populations) that can be ... \| read more...	$3,835.00
The 2010-2015 World Outlook for Cardiac Biomarkers 7/7/2009 \| published by: Icon Group International, Inc. ... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... \| read more...	$795.00
Personalized Medicine: Technologies and the Global Market 7/1/2009 \| published by: BCC Research ... for the worldwide market for personalized medicine Estimates the growth of all submarkets for personalized medicine in terms of technology, products, services, geography and applications areas Analyzes the current personalized medicine business model and looks ... \| read more...	$5,450.00

< prev 1 2 3 4 5 6 next >